OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
|Articles|August 1, 2007
- Volume 0 0
can you READ these Rxs?
Advertisement
When this prescription came into the pharmacy, Registered Pharmacist Dennis Nugent and Jon Marbach, CPhT, of Riverside Hometown Pharmacy in Riverside, NJ, were able only to determine that the prescribing physician was ordering 2 drugs. They immediately called the doctor's office for help. Can you correctly identify the medicines being ordered?
Click Here For The Answer ----------->
[
Imdur 60 mg, #30, 1 tablet daily, 3 refills; Digoxin 0.125 mg, #30, 1 tablet daily, 3 refills.
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
over 19 years ago
The Facts of Liceover 19 years ago
compounding HOTLINEover 19 years ago
can you READ these Rxs?over 19 years ago
WARFARIN-RELATED COMPLICATIONS INCREASE WITH AGEover 19 years ago
IS NATTOKINASE A NATURAL ALTERNATIVE TO WARFARIN?over 19 years ago
HIGH RATES OF WARFARIN-RELATED AEs IN NURSING HOMESover 19 years ago
LONG-TERM ASPIRIN USE MAY REDUCE RISK OF SOME CANCERSover 19 years ago
Embracing and Advocating Change in the Pharmacy Professionover 19 years ago
Improving Pharmaceutical Care of the Elderly Patient with GERDover 19 years ago
compounding HOTLINEAdvertisement
Related to this article
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
3
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5